期刊文献+

左归丸对实验性骨质疏松牙周炎大鼠牙周组织OPG、RANKL表达的影响 被引量:4

The effect of zuogui pill on the periodontitis of experimental rats with osteoporosis
下载PDF
导出
摘要 选取6月龄纯种雌性SD大鼠46只,随机分为4组,正常组(N组)10只,去势牙周炎组(OVX-PD组)12只,去势牙周炎戊酸雌二醇治疗组(ERT组)12只,去势牙周炎左归丸治疗组(ZGT组)12只。建立骨质疏松牙周炎动物模型并按分组用药,3个月后处死动物,检测牙周组织中的骨保护因子(OPG)、破骨细胞核因子КB受体活化因子配体(RANKL)。ZGT组、ERT组可见牙周袋变浅,牙槽骨可见新骨生成;ZGT组及ERT组牙周组织中OPG含量明显高于OVX-PD组(P<0.01),RANKL含量明显低于OVX-PD组(P<0.01)。 Osteoporosis modle was estabilished by ovariectomy and periodontitis by stainless wire ligation method.48 6-month-old female SD rats were randomly divided into four groups,normal group(N,n=10),ovariectomized periodontitis group(OVX-PD,n=12),ovariectomized periodontitis of estrogen treatment group(ERT,n=12),ovariectomized periodontitis zuogui pill therapy group(ZGT,n=12).3 months after medication,the animals were killed and the maxillars were taken for histological observation and the examinations of the expression of osteoprotegerin(OPG) and receptor activator of nuclear factor-КB ligand(RANKL) in periodontal tissue.Shallow periodontal pocket was found in ZGT and ERT groups,new bone formation was found in alveolar bone.In periodontal tissue OPG concentration in ZGT and ERT groups was higher than in OVX-PD group(P0.01),RANKL concentration in ZGT and ERT groups was lower than in OVX-PD group(P0.01).Zuogui Pill and estradiol valerate can prevent alveolar bone loss in rats with osteoporosis and periodontitis.
出处 《实用口腔医学杂志》 CAS CSCD 北大核心 2011年第2期270-273,共4页 Journal of Practical Stomatology
基金 河北省中医药管理局中医药 中西医结合科研计划课题(编号:2009107)
关键词 骨质疏松 牙周炎 左归丸 骨保护因子 破骨细胞核因子КB受体活化因子配体 Osteoporosis Periodontitis Zuogui pill OPG RANKL
  • 相关文献

参考文献8

  • 1Cheng PT,Chan C,Müller K.Cyclical treatment of ost-eopenic ovariectomized adual rats with PTH(1-34) and pamidronate[J].J Bone Miner Res,1995,10(1):119-126.
  • 2Simonet WS,Lacey DL,Dunstan CR,et al.Osteoprotegerin:A novel secreted protein involved in the regulation of bone density[J].Cell,1997,89(2):309-319.
  • 3Laey DL,Timms E,Tan HL,et al.Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation[J].Cell,1998,93(2):165-176.
  • 4Marie P,Halbout P.OPG/RANKL:Role and therapeutic target in osteoporosis[J].Med Sci (Pairs),2008,24(1):105-110.
  • 5Jin Q,Cirelli JA,Park CH,et al.RANKL inhibition through osteoproteger in blocks bone loss in experimental periodontitis[J].J Periodontol,2007,78(7):1300-1308.
  • 6曹亚飞,刘红敏,刘庆思.骨质疏松症的中医证型与治疗原则探讨[J].中国骨质疏松杂志,2002,8(4):367-369. 被引量:36
  • 7Hofbauer LC,Khosla S,Dunstan CR,et al.Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells[J].Endocrinology,1999,140(9):4367-4370.
  • 8鞠大宏,刘梅洁,赵宏艳,潘静华,刘红,张立石,于智敏,王燕平,于峥,贾朝娟,赵涛.左归丸含药血清对成骨细胞OPG、RANKL mRNA表达的影响[J].北京中医药大学学报,2008,31(5):312-315. 被引量:28

二级参考文献23

共引文献61

同被引文献64

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部